Loading...

Bullfrog AI Holdings, Inc. Common Stock

BFRGNASDAQ
Healthcare
Medical - Healthcare Information Services
$1.23
$-0.04(-3.15%)

Bullfrog AI Holdings, Inc. Common Stock (BFRG) Financial Performance & Income Statement Overview

Access detailed quarterly and annual financial reports for Bullfrog AI Holdings, Inc. Common Stock (BFRG), covering cash flow, earnings, and balance sheets.

Revenue Growth
-100.00%
100.00%
Operating Income Growth
-34.82%
34.82%
Net Income Growth
-30.58%
30.58%
Operating Cash Flow Growth
6.52%
6.52%
Operating Margin
-20339.60%
20339.60%
Gross Margin
18.64%
18.64%
Net Profit Margin
-19852.17%
19852.17%
ROE
-195.32%
195.32%
ROIC
-325.17%
325.17%

Bullfrog AI Holdings, Inc. Common Stock (BFRG) Income Statement & Financial Overview

Access detailed annual and quarterly income data for Bullfrog AI Holdings, Inc. Common Stock BFRG financial performance.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$0.00$1724.00$0.00$0.00
Cost of Revenue$0.00$862.00$0.00$431.00
Gross Profit$0.00$862.00$0.00-$431.00
Gross Profit Ratio$0.00$0.50$0.00$0.00
R&D Expenses$576260.00$590856.00$566584.00$513699.00
SG&A Expenses$1.48M$1.18M$1.25M$1.17M
Operating Expenses$2.06M$1.77M$1.82M$1.68M
Total Costs & Expenses$2.06M$1.77M$1.82M$1.68M
Interest Income$40082.00$260894.00$0.00$0.00
Interest Expense$1015.00$2008.00$4978.00$7899.00
Depreciation & Amortization$431.00$431.00$431.00$431.00
EBITDA-$2.02M-$1.71M-$1.76M-$1.60M
EBITDA Ratio$0.00-$993.22$0.00$0.00
Operating Income-$2.06M-$1.77M-$1.82M-$1.68M
Operating Income Ratio$0.00-$1025.96$0.00$0.00
Other Income/Expenses (Net)$39067.00$54018.00$56477.00$70317.00
Income Before Tax-$2.02M-$1.71M-$1.76M-$1.61M
Income Before Tax Ratio$0.00-$994.63$0.00$0.00
Income Tax Expense$0.00$0.00$0.00$0.00
Net Income-$2.02M-$1.71M-$1.76M-$1.61M
Net Income Ratio$0.00-$994.63$0.00$0.00
EPS-$0.21-$0.21-$0.22-$0.20
Diluted EPS-$0.21-$0.21-$0.22-$0.20
Weighted Avg Shares Outstanding$9.69M$8.25M$8.12M$8.12M
Weighted Avg Shares Outstanding (Diluted)$9.69M$8.25M$8.12M$8.12M

The company's financials show resilient growth, with revenue advancing from $0.00 in Q2 2024 to $0.00 in Q1 2025. Gross profit remained healthy with margins at N/A in Q1 2025 compared to N/A in Q2 2024. Operating income hit -$2.06M last quarter, sustaining a consistent N/A margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$2.02M. Net income dropped to -$2.02M, while earnings per share reached -$0.21. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;